Volume 6, Issue 4
Review Articlep. 497
Treatment of hypertension in the diabetic patient
Author(s): Amgad N Makaryus and Samy I McFarlane
Review Articlep. 489
Lifestyle management: preventing Type 2 diabetes and cardiovascular complications
Author(s): Rebecca S Stiegler, Paul Z Zimmet, Adrian J Cameron and Jonathan E Shaw
Research Articlep. 595
Chemotherapy-induced nausea and vomiting in Portugal: incidence versus healthcare provider estimations and effect on quality of life
Author(s): Jose Dinis, Tami Wisniewski, Antonio Moreira, Joao Raposo, Larry Ma & Thomas A Burke
Review Articlep. 507
Glycemic control and cardiovascular disease in a high-risk chronic kidney disease population
Author(s): Rachandeep Singh, Ravi Nistala, Samy I McFarlane and Adam Whaley-Connell
Editorialp. 459
Does normalization of blood glucose reduce the rate of cardiovascular events?
Author(s): Sabreena Basu
Review Articlep. 603
Novel strategies and future landmarks in the treatment of irritable bowel syndrome
Author(s): Richard Roka, Krisztina Gecse and Tibor Wittmann
Research Highlightsp. 469
Fenofibrate effects on cardiovascular outcomes in patients with diabetes and metabolic syndrome
Author(s): Brian K Irons
Bulletin Boardp. 546
Bulletin Board: Volume 6 Issue 4
Drug Evaluationp. 569
Pemetrexed in the treatment of malignant pleural mesothelioma
Author(s): Michael D Peake
Drug Evaluationp. 577
Ofatumumab for the treatment of chronic lymphocytic leukemia
Author(s): Tadeusz Robak
Bulletin Boardp. 545
Influenza: the story continues�
News and Viewsp. 463
Diabetes and cardiovascular outcomes
Review Articlep. 515
Hyperglycemia, dyslipidemia and hypertension in older people with diabetes: the benefits of cardiovascular risk reduction
Author(s): Siobhan HM Brown and Ahmed H Abdelhafiz
Special Reportp. 531
Pharmacogenomics and the prevention of vascular complications in diabetes mellitus
Author(s): Dan Farbstein and Andrew P Levy
Drug Evaluationp. 553
Lapatinib in the management of breast cancer
Author(s): Peter S Hall, Jaishree Bhosle and David A Cameron
Case Reportp. 589
Efficacy of clobazam monotherapy in three cases of symptomatic localization-related epilepsy in children
Author(s): Toshiyuki Iwasaki, Yutaka Nonoda, Kenji Takei, Nozomi Hosoda and Masahiro Ishii
Appendicesp. 621
Appendices: Volume 6 Issue 4
Appendicesp. 619
Glossary: Volume 6 Issue 4
Forewordp. 451
Diabetes and cardiovascular disease: time for individualized risk reduction
Author(s): Samy I McFarlane and James R Sowers
Drug Evaluationp. 475
Colesevelam hydrochloride: a bile acid sequestrant for glycemic control and treatment of dyslipidemia in Type 2 diabetes mellitus
Author(s): Prasanth N Surampudi, Prathima Nagireddy and Vivian A Fonseca
Editorialp. 541
Will computational simulation in congenital heart disease ever make it out of the engineering lab and into the clinic?
Author(s): Alison L Marsden and Jeffrey A Feinstein
Conference Proceedingp. 615
Updates on the clinical practice of emergency medicine
Author(s): Dale S Birenbaum
Appendicesp. 628
Author Guidelines: Volume 6 Issue 4
Appendicesp. 627
